Merck & Co. Inc. buy BMO Capital Markets
Start price
18.12.25
/
50%
€85.40
Target price
18.12.26
€110.75
Performance (%)
54.54%
Price
16:20
€131.98
Summary
This prediction is currently active. With a performance of 54.54% the BUY prediction by BMO_Capital_Markets is a big success. This prediction currently runs until 18.12.26. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Merck & Co. Inc. | 8.621% | 8.621% |
| iShares Core DAX® | -1,59 % | 5,03 % |
| iShares Nasdaq 100 | -4,15 % | -0,13 % |
| iShares Nikkei 225® | -6,30 % | 0,53 % |
| iShares S&P 500 | -3,23 % | 0,47 % |
Comments by BMO_Capital_Markets for this prediction
In the thread Merck & Co. Inc. diskutieren
Merck & Co., Inc. (NYSE:MRK) was upgraded by analysts at BMO Capital Markets from a "market perform" rating to an "outperform" rating. They now have a $130.00 price target on the stock, up previously from $82.00.
Ratings data for MRK provided by MarketBeat
Stopped prediction by BMO_Capital_Markets for Merck & Co. Inc.
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€94.50
01.11.24
01.11.24
€125.35
01.11.25
01.11.25
-20.95%
02.11.25
02.11.25
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€101.00
27.10.23
27.10.23
€125.02
27.10.24
27.10.24
-4.06%
28.10.24
28.10.24